Platinum Investment Management Ltd. Takes $1.60 Million Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Platinum Investment Management Ltd. purchased a new stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 19,138 shares of the biopharmaceutical company’s stock, valued at approximately $1,598,000. Several other hedge funds have also made changes to their positions in the company. Seven Eight Capital LP purchased […]

Related Keywords

United States , America , Robert Arthur Harrington , Fady Ibraham Malik , Raymond James , Rafferty Asset Management , Cytokinetics Company Profile , Platinum Investment Management Ltd , Cytokinetics Incorporated , Asset Management Inc , Platinum Investment Management , Free Report , Eight Capital , Point Capital , Hill Management Partners , Asset Management , Management Inc , Ibraham Malik , Director Robert Arthur Harrington , Get Free Report , Visit Holdingschannel , Cytokinetics Daily ,